The Autism Impact Fund (AIF), whose mission is to revolutionise the status quo for diagnosing, treating, and living with autism through a venture capital model, has formed a strategic partnership with Arsenal Capital Partners (Arsenal), a private equity firm specialising in building transformational businesses across healthcare, have entered into a strategic partnership.
AIF and Arsenal will share their respective expert networks and diligence resources to pursue innovative investment opportunities in the growing behavioral health market.
Founded in 2021, AIF has invested in 10 companies, including early-stage and growth businesses. AIF makes direct investments across diverse sectors and stages of financing, and is guided by four key values: 1) invest in companies that will produce significant advancements in quality of life for the Autism Spectrum Disorder (ASD) community; 2) provide access to best-in-class services, diagnostics, and therapeutics; 3) apply rigorous investing criteria to deliver returns not only to investors but to all stakeholders, including ASD individuals and their families; 4) rewrite the impact investing equation, overlaying financial discipline and proven business strategies with scientific acumen to improve the status quo for individuals with autism.
